Double blinded and placebo controlled examination to observe the effects of the water containing 7ppm molecular hydrogen on the EndPAT test

Double blinded and placebo controlled examination to observe the effects of the water containing 7ppm molecular hydrogen on the EndPAT test - An examination to observe the effects of the water containing 7ppm molecular hydrogen on the EndPAT test

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032523

Enrollment

Registered

2018-05-10

Start date

2015-07-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy subjects

Interventions

Daily consumption of the water containing 7ppm molecular hydrogen for 14 days/Daily consumption of the placebo water for 14 days. In detail, the healthy volunteers were informed individually about th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy volunteers

Exclusion criteria

Exclusion criteria: All of the subjects took medications or dietary supplements or received medical treatments within 6 months before this study was performed.

Design outcomes

Primary

Measure	Time frame
Improvement of Reactive hyperemia index(RHI)	—

Countries

Japan

Contacts

Public ContactToru Ishibashi

Huis Ten Bosch Satellite H2 Clinic Hakata Department of rheumatology

info@h2-clinic.jp+81-92-282-5005

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026